<DOC>
<DOCNO>
EP-0008665
</DOCNO>
<TEXT>
<DATE>
19800319
</DATE>
<IPC-CLASSIFICATIONS>
C07F-9/00 C07D-307/54 C07D-307/42 A61K-31/34 C07D-307/46 C07F-9/655 C07D-307/00 <main>C07D-307/42</main> 
</IPC-CLASSIFICATIONS>
<TITLE>
furyl-nonatetraene derivatives and the pharmaceutically acceptable salts thereof, processes for their preparation, starting compounds used in these processes, and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
hoffmann la rochech<sep>f.hoffmann-la roche & co. aktiengesellschaft<sep>f. hoffmann-la roche &amp; co. aktiengesellschaftpostfach 32554002 baselch<sep>f. hoffmann-la roche & co. aktiengesellschaft <sep>
</APPLICANT>
<INVENTOR>
rosenberger michael<sep>rosenberger, michael<sep>rosenberger, michael79 arlington avenuecaldwell, n.j.us<sep>rosenberger, michael<sep>rosenberger, michael79 arlington avenuecaldwell, n.j.us<sep>
</INVENTOR>
<ABSTRACT>
the new furyl-nonatetraene derivatives of the formula    and the pharmaceutically acceptable salts thereof, e. g.  (e,e,e,­ e,) -3,7-dimethyl-9-(2,4,5-trimethyl-3-furyl)- 2,4,6,8-­ nonatetraenoic acid ethyl ester, are effective in regressing the  growth of tumors and chondrosarcoma and they are useful as  medicaments for therapy of acne, psoriasis and other der­ matological disorders.  they may be therefore included in  pharmaceutical preparations.  the compounds of the formula i may be prepared by a  process which comprises   a) reacting a compound of the formula   b-c(ch₃) = ch-ch = ch-c(ch₃) = ch-coor¹⁰ ii   with a new compound of the formula    or   b) reacting a new compound of the formula    with a compound of the formula   ho(ch₂)nn(r⁷r⁸) v   or   hn(r₇r⁸) vi   the meaning of the substituents see inside the description.  
</ABSTRACT>
</TEXT>
</DOC>
